InspireMD (NYSE:NSPR) has released the results of a meta-analysis of four clinical studies involving dual-layered (DLS) and mesh-covered stents, including the company’s MicroNet-covered stent, the CGuard embolic prevention system. The analysis concluded that carotid artery disease patients treated with mesh-covered stents experienced a 30-day minor stroke rate of 1.25%, lower than the 30-day minor stroke rates reported in […]
Terumo
The 10 largest medtech employers of 2018 – and what their employees really think
Among the 10 largest medtech employers, workers feel pride in working on life-saving products – but there’s also frustration with big corporate bureaucracy. That was the major takeaway as Medical Design & Outsourcing compiled some of the most insightful current and former employee reviews posted on Glassdoor. The 10 companies we’re counting down were the largest […]
ivWatch to integrate IV infiltration sensor into Philips’ patient monitors
For decades, nurses have sent drugs surging through a patient’s body using the power of the circulatory system. Catheters deliver medications destined to travel through a person’s veins – but it doesn’t always turn out that way. Sometimes, leaky veins cause drugs to seep into surrounding tissue or to back out of the insertion site, […]
Terumo’s MicroVention wins expanded FDA indications for Sofia cath
Terumo (OTC:TRUMY;TYO:4543) subsidiary MicroVention said today it won FDA clearance for a new clinical indication for its Sofia catheter designed for intracranial access, now cleared for contact aspiration procedures to treat acute ischemic stroke. The company said it won CE Mark approval in the European Union for the aspiration in 2015, and that the device has been used […]
Terumo’s Vascutek, Bolton Medical merge to form Terumo Aortic
Terumo Corp. (TYO:4543) said today its Vascutek subsidiary and Bolton Medical have merged together to form a new company, Terumo Aortic. The newly combined company is expected to have a revenue of more than $200 million, and will employ more than 1,100 individuals worldwide, Tokyo-based Terumo said. Terumo Aortic will look to accelerate its position in treating aortic […]
Terumo pays at least $20m for Medeon Biodesign’s XPro vascular closure device
Medeon Biodesign (TPEx:6499) said today that it agreed to sell its XPro suture-mediated vascular closure device to Terumo Corp. (TYO:4543) for $20 million up front, plus milestones. The XPro device is designed for vascular closure following transcatheter aortic valve replacement, endovascular aneurysm repair, thoracic endovascular aneurysm repair and percutaneous balloon aortic valvuloplasty procedures. Medeon said it plans […]
7 medtech stories we missed this week: Sept. 29, 2017
From EOI getting FDA clearance to Sanuwave’s new joint venture agreement, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. EOI wins FDA nod for FLXfit15 expandable cage EOI announced in a Sept. 28 press release that it has received FDA 510(k) clearance for its FLXfit 15. The clearance […]
GE Healthcare CEO Flannery promoted to GE’s corner office | Personnel Moves – June 12, 2017
Former GE Healthcare (NYSE:GE) head John Flannery will be stepping into the corner office for all of GE, replacing Jeff Immelt who is stepping aside after 16 years as head of the large conglomerate. The CEO transition will go into effect Aug. 1, while Flannery will also take over as board chair after Immelt retires on […]
Terumo, U Penn face heater-cooler infection lawsuit
Terumo Corp. (TYO:4543) and the University of Pennsylvania are facing a suit from a New Jersey woman who claims to have contracted a serious bacterial infection from a Terumo HX2 heater-cooler device during a heart surgery last year, according to a press release published yesterday. Counsel for the plaintiff, Marisa Karamonoogian, said that her and her husband […]
Terumo launches Mirasol pathogen reduction tech trial
Terumo Corp. (TYO:4543) said today it launched the Miplate clinical trial of its Mirasol pathogen reduction technology system and enrolled the 1st patient in the study. In the trial, Terumo will look to evaluate the effectiveness of Mirasol-treated apheresis platelets in plasma versus standard apheresis platelets in plasma, hoping that the data will support FDA premarket […]
ReThink Medical raises $3m in Series A
Heart failure medical device developer ReThink Medical said today it raised $3 million in a Series A funding round, with funds slated to support clinical trials and further technology development. The company is developing proprietary algorithms to predict worsening conditions in heart failure patients and alert physicians to take proactive measures for their patients. ReThink […]